RBC Capital analyst Ben Hendrix lowered the firm’s price target on Universal Health (UHS) to $201 from $211 and keeps a Sector Perform rating on the shares. The company reported a “solid” Q1, but shares traded lower post-call on Tuesday on difficult volume optics in the behavioral segment and concern over the ramp to behavioral guidance through the balance of the year, the analyst tells investors in a research note. RBC adds however that it is encouraged by signs of momentum in late March and April.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health’s Strong Financial Performance Justifies Buy Rating Despite Revenue Shortfall
- Universal Health Services Reports Strong Q1 2025 Results
- Universal Health’s Strong Financial Performance and Strategic Positioning Earns Buy Rating
- Universal Health’s Mixed Q1 Performance and Strategic Uncertainty Justify Hold Rating
- Cautious Hold Rating on Universal Health Amid Mixed Segment Performance and Policy Risks